KRON
Income statement / Annual
Last year (2024), Kronos Bio, Inc.'s total revenue was $9.85 M,
an increase of 56.62% from the previous year.
In 2024, Kronos Bio, Inc.'s net income was -$86.08 M.
See Kronos Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$9.85 M |
$6.29 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$4.26 M
|
$0.00
|
$4.46 M
|
$4.08 M
|
$4.87 M
|
$605,000.00
|
$160,000.00
|
| Gross Profit |
$5.59 M
|
$6.29 M
|
-$4.46 M
|
-$4.08 M
|
-$4.87 M
|
-$605,000.00
|
-$160,000.00
|
| Gross Profit Ratio |
0.57
|
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$48.66 M
|
$86.38 M
|
$93.72 M
|
$112.90 M
|
$43.25 M
|
$13.45 M
|
$5.03 M
|
| General & Administrative Expenses |
$24.62 M
|
$41.74 M
|
$43.40 M
|
$38.50 M
|
$14.79 M
|
$3.37 M
|
$1.61 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$24.62 M
|
$41.74 M
|
$43.40 M
|
$38.50 M
|
$14.79 M
|
$3.37 M
|
$1.61 M
|
| Other Expenses |
$29.46 M
|
$0.00
|
$0.00
|
$0.00
|
-$27.41 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$102.74 M
|
$128.12 M
|
$137.12 M
|
$151.40 M
|
$58.04 M
|
$16.82 M
|
$6.65 M
|
| Cost And Expenses |
$102.74 M
|
$128.12 M
|
$137.12 M
|
$151.40 M
|
$58.04 M
|
$16.82 M
|
$6.65 M
|
| Interest Income |
$6.81 M
|
$9.16 M
|
$3.91 M
|
$320,000.00
|
$898,000.00
|
$699,000.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.89 M
|
$0.00
|
$76,000.00
|
| Depreciation & Amortization |
$1.72 M
|
$2.14 M
|
$4.46 M
|
$4.08 M
|
$4.87 M
|
$605,000.00
|
$160,000.00
|
| EBITDA |
-$61.72 M |
-$119.69 M |
-$128.74 M |
-$147.00 M |
-$79.69 M |
-$15.51 M |
-$6.49 M |
| EBITDA Ratio |
-6.27
|
-19.04
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-9.43
|
-19.38
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$6.81 M
|
$9.16 M
|
$3.91 M
|
$320,000.00
|
-$30.40 M
|
$699,000.00
|
-$76,000.00
|
| Income Before Tax |
-$86.08 M
|
-$112.67 M
|
-$133.20 M
|
-$151.08 M
|
-$88.44 M
|
-$16.12 M
|
-$6.72 M
|
| Income Before Tax Ratio |
-8.74
|
-17.92
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$3.91 M
|
-$1.98 M
|
-$24.36 M
|
-$699,000.00
|
-$70,141.00
|
| Net Income |
-$86.08 M
|
-$112.67 M
|
-$129.29 M
|
-$149.10 M
|
-$64.09 M
|
-$15.42 M
|
-$6.72 M
|
| Net Income Ratio |
-8.74
|
-17.92
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.43 |
-1.95 |
-2.3 |
-2.72 |
-1.19 |
-0.29 |
-0.24 |
| EPS Diluted |
-1.43 |
-1.95 |
-2.3 |
-2.72 |
-1.19 |
-0.29 |
-0.24 |
| Weighted Average Shares Out |
$60.07 M
|
$57.74 M
|
$56.20 M
|
$54.75 M
|
$54.07 M
|
$53.04 M
|
$28.45 M
|
| Weighted Average Shares Out Diluted |
$60.07 M
|
$57.74 M
|
$56.20 M
|
$54.75 M
|
$54.07 M
|
$53.04 M
|
$28.45 M
|
| Link |
|
|
|
|
|
|
|
